1. |
Farand P, Hamel M, Lauzier F, et al. Organ perfusion/permeabilityrelated effects of norepinephrine and vasopressin in sepsis. Crit Care Med, 2006, 34: 1647-1653.
|
2. |
林洪遠. 膿毒癥的免疫調理治療. 中國醫師進修雜志, 2006,29: 8-10.
|
3. |
Giamarellos-Bourboulis EJ, Routsi C, Plachouras D, et al. Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? Critical Care, 2006, 10: R76 -R83.
|
4. |
Le Tulzo Y, Pangault C, Gacouin A, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock, 2002 , 18: 487-494.
|
5. |
Felmet KA, Hall MW, Clark RS, et al. Prolonged lymphopenia,lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple 0rgan failure. J Immunol, 2005, 174 :3765-3772.
|
6. |
杜斌, 陳德昌, 劉大為, 等. 感染相關的器官衰竭評分對多器官功能障礙綜合征預后判斷的意義. 中華醫學雜志, 2001, 81: 78 -81 .
|
7. |
蔣賢高, 汪曉波, 王仁數. 膿毒血癥患者監測血清降鈣素原、C 反應蛋白的臨床意義. 中國呼吸與危重監護雜志, 2009, 8: 429 -431.
|
8. |
Kox WJ, Volk T, Kox SN, et al. Immunomodulatory therapies in sepsis. Intensive Care Med, 2000, 26: S124-S128.
|